Candidate Genes Associated with Tumor Regression Mediated by Intratumoral Il-12 Electroporation Gene Therapy
Open Access
- 31 March 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (3) , 347-354
- https://doi.org/10.1016/j.ymthe.2003.11.022
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Regression of tumors by IFN-α electroporation gene therapy and analysis of the responsible genes by cDNA arrayGene Therapy, 2002
- Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant siteCancer Gene Therapy, 2001
- How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 geneThe EMBO Journal, 2000
- Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cellsCancer Gene Therapy, 2000
- Interleukin-12 as an Adjuvant for Cancer ImmunotherapyMethods, 1999
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- T Cell Receptor (TCR) Mini-Gene mRNA Expression Regulated by Nonsense Codons: A Nuclear-associated Translation-like MechanismThe Journal of Experimental Medicine, 1997
- Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling PathwayCell, 1996
- IFN-γ Induces IL-12 mRNA Expression by a Murine Macrophage Cell Line, J774Biochemical and Biophysical Research Communications, 1994
- Cytokine-Induced Tumor Immunogenicity: From Exogenous Cytokines to Gene TherapyJournal of Immunotherapy, 1993